An Innovation Roadblock: The Shrinking Availability of Venture Capital in MedTech
Posted January 19, 2018| Prem Meyyan
The medical device sector, like many health segments, is driven by the usual suspects: a growing elderly population, rising prevalence of debilitating diseases, increased importance on quality-of-life, and innovation through painstaking research and development (R&D) efforts.
R&D is the only factor that industry players have any influence over and presents significant potential to cause a paradigm shift in the medical device innovation we introduce and overall, how we approach the treatment and management of diseases via MedTech. By extension, innovation, whether in technological hardware or software or other key elements, could drive explosive growth across numerous product segments. What’s the challenge, then? In a word: funding.
Our health + life science consulting group investigated why innovation is stymied by lack of funding. Download the whitepaper to learn more.